Contact
Thank you for your time and interest in Exchange Traded Products
Contact Morgan Stanley
For general enquiries regarding Exchange Traded Products, please use contact details below:
Email: etpfrance@morganstanley.com
Product Details
Turbo Infinis | Short | Novo Nordisk B | 271.07 | 282.2978
- WKN: MN3W69
- ISIN: DE000MN3W693
- Turbo Infinis
Product Sold Out - Bid only
Daily Change (Bid)
-37.50 %-0.18 EUR 24.04.2026 17:03:06
Underlying
259.28 DKK
+5.23 % 24.04.2026 17:04:43
Risk Factors
| Leverage Risk | Yes |
| Market Risk | Yes |
| Counterparty Risk | Yes |
| Currency Risk | Yes * |
*No currency risk exists if the product in question is based on your domicile currency.
Disclaimer
The financial instruments are associated with risks and therefore you should not buy the financial instruments described on this website unless you are prepared to sustain a total loss of the investment plus any commission or other transaction charges that may be incurred. The financial instruments described on this website are complex securities and may be difficult to understand. You should not buy these securities unless you are a sophisticated investor who understands and has previous experience in investing in such products. Potential investors should read the prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with the securities. The approval of the prospectus by the relevant competent authority should not be understood as an endorsement of the securities.
Key figures
| Financing Level | 282.2978 DKK |
| Stop Loss Level | 271.07 DKK |
| Distance to stop loss level | 4.21 % |
| Leverage | 11.20 |
| Ratio | 10 |
| Multiplier | 0.1 |
Base Data
| Name | Turbo Infinis | Short | Novo Nordisk B | 271.07 | 282.2978 |
| WKN | MN3W69 |
| ISIN | DE000MN3W693 |
| Issuer | MORGAN STANLEY & CO. INTERNATIONAL |
| Currency | EUR |
| Product Type | Turbo Infinis |
| Underlying | Novo Nordisk B |
| Currency | DKK |
| Underlying ISIN | DK0062498333 |
| Financing Spread p.a. | 5.00 % |
| First Day Of Trading | 25.02.2026 |
Price Data
| Daily Change (Bid) | -0.18 EUR |
| -37.50 % | |
| Last Update | 24.04.2026 17:03:06 |
| Day High | 0.51 EUR |
| Day Low | 0.25 EUR |
Documents
Risk Factors
| Leverage Risk | Yes |
| Market Risk | Yes |
| Counterparty Risk | Yes |
| Currency Risk | Yes * |
*No currency risk exists if the product in question is based on your domicile currency.
Disclaimer
The financial instruments are associated with risks and therefore you should not buy the financial instruments described on this website unless you are prepared to sustain a total loss of the investment plus any commission or other transaction charges that may be incurred. The financial instruments described on this website are complex securities and may be difficult to understand. You should not buy these securities unless you are a sophisticated investor who understands and has previous experience in investing in such products. Potential investors should read the prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with the securities. The approval of the prospectus by the relevant competent authority should not be understood as an endorsement of the securities.
Documents
Events
| Date | Events | Adjustments | Value Before Event | Value After Event |
|---|---|---|---|---|
| 27/03/2026 | Cash Dividend |
|
|
|
Base Data
| Name | Stammaktie der Novo Nordisk A/S (Class B) |
| WKN | A3EU6F |
| ISIN | DK0062498333 |
| Bloomberg Code | NOVOB DC Equity |
| Currency | DKK |
Price Data
| Name | Stammaktie der Novo Nordisk A/S (Class B) |
| Day High | 263.12 DKK |
| Day Low | 244.03 DKK |
| Close Last Trading Day | 246.39 DKK |
| Last Update | 24/04/2026 17:04:43 |